The Global Amniotic Membranes Industry is poised to achieve a value of approximately US$ 1.4 billion in 2022, and it is expected to exhibit an impressive Compound Annual Growth Rate (CAGR) of 9.0% from 2022 to 2028, ultimately reaching over US$ 2.3 billion by the close of 2028. This growth is attributed to the rising adoption of amniotic membranes in ophthalmology and is detailed in the ‘Global Amniotic Membrane Market’ report by Future Market Insights.
The report predicts a CAGR of 9.3% from 2018 to 2028, with the market estimated at US$ 955.2 million in 2018, set to surpass US$ 2,322 million by 2028. Cryopreserved amniotic membranes hold a dominant 70% market share, projected to grow at a 9% CAGR through 2018–2028. North America is expected to maintain its lead, driven by regulatory approvals for new products in the U.S.
Request a Sample of this Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-5044
The population of all age groups has emerged as a prominent consumer base, characterised by untapped product segments for amniotic membranes to offer effective wound healing and eye surgeries. This has prompted the amniotic membrane product manufacturers to capitalize on the emerging latent opportunity. The companies in the market are optimistic about increasing amniotic membrane transplants and increasing demand for amniotic membrane products around the world, particularly in North American countries. It is more than likely that over the next four to five years, the companies focus on developing innovative products and designing market-level strategies to leverage the potential opportunities emerging in parallel with the growing human population with various chronic diseases.
Amniotic membrane products such as Amniotic Allograft Membrane and Amniotic Allograft Suspension used to treat surgical wounds and defects of the corneal epithelia have gained traction over the last two decades. The major types of amniotic membranes such as cryopreserved amniotic membranes and lyophilized amniotic membranes evolved back in the 1990s, but they became significant and the market for amniotic membranes to be used on humans boomed over the past fifteen years.
The global amniotic membrane market has been segmented based on product type, application, end-user and regions. Globally, cryopreserved amniotic membrane is the most attractive segment from manufacturers’ point of view. Cryopreserved amniotic membrane is majorly used in ocular surface eye surgery owing to its positive effect on wound healing due to its anti-inflammatory properties. Among all end users of amniotic membranes, high demand for amniotic membranes is expected to come from the hospital segment due to the rising application of amniotic membranes in advanced surgical healing.
By volume
The global amniotic membrane market is expected to expand at 11.4% over the forecast period of 2018–2028. With nearly 43% market value share, North America dominated the global amniotic membrane market in 2017, partly due to the penetration of newly approved products in the U.S. Western Europe, the second largest market globally, with the U.K., France and Germany being countries with high growth rates., is expected to gain 110 BPS in its market share over 2018–2028. APEJ is expected to be the third-largest market for amniotic membranes. APEJ and China collectively are expected to contribute over 15% share in the global market by 2028 over 2018.
The market for amniotic membranes is highly consolidated with the top 5 players contributing over 60% of the revenue share in 2017.
Click Here to Request Methodology!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-5044
Examples of some of the key players identified in the global market are Integra
- LifeSciencesm Inc.
- MiMedx Group, Inc.
- Alliqua BioMedical, Inc.
- Skye Biologics Inc.
- Katena Products, Inc.
- Tissue-Tech Inc.
- Amnio Technology, LLC
- Applied Biologics LLC
- Human Regenerative Technologies, LLC
Depth of research, along with proper documentation and statistical validation are factors that could determine a player’s success in the global amniotic membrane market
Some of the key points identified in the global amniotic membrane market are:
- FMI forecasts the global amniotic membrane market to grow at a CAGR of 9.3% over the forecast period by 2028 end. The growth in revenue generation across the amniotic membrane market is registered on the account of rise in amniotic membrane transplants in both developed and developing economies.
- The hospitals segment has proved to be the leading end-user segment on account of the increase in several amniotic membrane transplants, and growing awareness among the people about the benefits of the amniotic membrane transplant.
- Ease of FDA approval for novel and innovative amniotic membrane allografts coupled with the adoption of amniotic membranes for varied applications would boost the revenue growth in Germany & the U.S. markets.
- Most often, apart from major applications including surgical wound and ophthalmology, the use of amniotic tissue in orthopaedic surgery, sports medicine and podiatry treatment has increased in recent years.
- The amniotic membranes used majorly to treat human surgical wound needs to be FDA-approved, thus amniotic membrane manufacturers focus on getting fast FDA approvals.
Click Here To Buy Your Detailed Report
https://www.futuremarketinsights.com/checkout/5044
Key Segments of Global Amniotic Membranes Industry Survey
Global Amniotic Membranes Industry by Product Type:
- Cryopreserved Amniotic Membranes
- Lyophilized Amniotic Membranes
Global Amniotic Membranes Industry by Application:
- Surgical Wounds
- Ophthalmology
- Others
Global Amniotic Membranes Industry by End User:
- Amniotic Membrane Treatment in Hospitals
- Amniotic Membrane Treatment in Specialized Clinics
- Amniotic Membrane Treatment in Ambulatory Surgical Centres
- Amniotic Membrane Treatment in Academic Research Centres
Global Amniotic Membranes Industry by Region:
- North America Amniotic Membranes Market
- Latin America Amniotic Membranes Market
- Europe Amniotic Membranes Market
- East Asia Amniotic Membranes Market
- South Asia & Pacific Amniotic Membranes Market
- Middle East & Africa (MEA) Amniotic Membranes Market
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges clients face and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
